Redeye comments on Avensia’s November sales figures.
Redeye is encouraged by AAC’s announcement this morning, where Bonnier Capital, through a directed i...
Redeye briefly comments on Truecaller releasing an update regarding its Q4 2025 revenue development,...
Aktia’s Q3 showed that frequent changes during 2025 did not have a visible impact on the bank; on th...
On 11 December 2025, Hella announced its first series production order for High-Resolution Radar (HR...
* The rights issue added MSEK 42 before loan offset * Fenja Capital II provides loan facility of MSE...
Smart Eye has successfully issued a SEK300m senior unsecured bond at 3M STIBOR + 7%, which we view a...
* Careium states that it will not meet FY'25 outlook.
Vi inleder bevakning på Online Brands Nordic, en snabbväxande e-handelskoncern som förvärvar, äger o...
Redeye comments on Optomed’s directed share issue, raising EUR6.
I väntans tider med rekordkvartal i ryggen för Railcare: Nya uppdrag bör rulla in under vintern för ...
Redeye comments on the subscription rate in Active Biotech's rights issue.
Kalqyl och Fairvalue lanserar nu NGM Company Insights, en samlad genomgång av nio tillväxtbolag note...
We raise our base case after having evaluated the financial situation of Verrica, which raised USD50...
* Mark Waugh appointed new CEO * Relevant background from orthapaedic industry * Supportive for sent...
OssDsign this morning announces the appointment of Mark Waugh as new CEO, effective 1 January.
Redeye comments on the recently announced TetraGraph order from one of the leading NHS hospital trus...
OXE Marine has signed a new financing agreement securing a total of SEK49m to facilitate the transfe...
* Ny levereans till Chr. Olesen inom ramen för avropsordern * Ordern motsvarar cirka 2,6 MSEK * Kort...
After publishing strong data with BI-1808 yesterday, BioInvent returns with a positive readout with ...
